For those hesitant in getting jabbed with the relatively new technology represented by mRNA vaccines, it might be reassuring to know that the old-fashioned way still works. In fact, laboratory studies found that two doses of the Sanofi-GSK vaccine stimulated the production of more neutralizing antibodies than mRNA vaccines already on the market, according to the companies.